MedPath

InPractice Survey on the Treatment of Hypercholesterolemia

Completed
Conditions
Hypercholesterolemia
Registration Number
NCT00523796
Lead Sponsor
AstraZeneca
Brief Summary

This is a multi-centre survey of patients who are currently on lipid-lowering pharmacological treatment. Data collection for each patient will take place at one visit.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2500
Inclusion Criteria
  • Subject must be 18 years of age or older of either sex.
  • Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.
Read More
Exclusion Criteria
  • Subjects who are unwilling or unable to provide informed consent.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research Site

🇻🇳

Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath